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We prospectively studied the surgical aspects, functional results, and 
complications of video-assisted bilateral thoracoscopic volume reduction 
surgery in patients with severe diffuse pulmonary emphysema. Methods: 
Fifteen men and five women with a mean age of 64 years (range 42 to 78 
years) Whose daily activity was substantially impaired by severe airflow 
obstruction and hyperinflation underwent thoracoscopic volume reduction 
surgery. The prospective preoperative assessment and postoperative as- 
sessment at 3 months included (1) pulmonary function studies, (2) grading 
of dyspnea, and (3) exercise performance; pulmonary function tests were 
also performed immediately before discharge from the hospital. Results: 
There was no perioperative mortality. All patients left the hospital after a 
median stay of 15 days (6 to 27 days). Only seven patients had a prolonged 
chest tube drainage time (>7 days). At 3 months the mean (± standard 
deviation) forced expiratory volume in 1 second had improved by 42% 
(-+3.8%), from 0.80 L (+0.23) to 1.09 L (-+0.28) (p < 0.00l); residual 
volume had decreased from 5.8 L (+1.5) to 4.4 L (-1.0) (p < 0.001). Shortly 
before discharge the forced expiratory volume in l second was already 1,10 
L (±0.26). The median 12-minute walking distance increased from 495 m 
(35 to 790 m) to 688 m (175 to 1035 m) (p < 0.001) and the mean maximal 
oxygen consumption from 10 ml/kg per minute (±2.5) to 13 ml/kg per 
minute (-+2.3) (p < 0.0005). The patients reported a substantial relief of 
dyspnea with a mean decrease in the Medical Research Council score from 
3.4 to 1.8. (J Thorac Cardiovasc Snrg 1996;112:875-82) 
R esection of large bullae, either unilaterally by thoracotomy or bilaterally by median sternot- 
omy, has been performed with good functional 
results for many years by numerous groups. ~-6 Re- 
section of large bullae, that is, bullae along with at 
least one third of a hemithorax and minimal or 
moderate remaining emphysematous lung tissue, 
resulted in the most impressive improvement. 6 
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A totally different concept was pioneered by Bran- 
tigan, Mueller, and Kress 7 more than 30 years ago. 
Their procedure consisted of multiple wedge resec- 
tions of emphysematous l ng tissue through a stan- 
dard thoracotomy. Their goal was to reduce lung 
volumes, hence improving radial traction on the air- 
waysJ -9 A high perioperative mortality of 16%, the 
lack of appropriate functional documentation f the 
patients, and prejudices discouraged other physicians 
from following this approach. Cooper and associates l° 
resumed Brantigan's concept and performed bilateral 
lung volume reduction surgery (VRS) in patients who 
had grossly hyperinflated lungs because of severe 
diffuse pulmonary emphysema. They used median 
sternotomy as a surgical approach. Because of our 
experience and good results with video-assisted thora- 
coscopy (VAT) for a variety of indications, we pro- 
spectively studied the surgical problems, complica- 
tions, and functional results of VRS performed by this 
approach. We expected to obtain functional improve- 
ments comparable with those obtained with median 
sternotomy. 
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Table I. Emphysema severity scores assessed by computed tomography 
Left lung* Right lung* 
Patient UL Lingula LL UL ML LL Total score Emphysema typep 
1 1.5 1.0 1.5 1.5 0.5 0.5 6.5 Uniform 
2 3.0 0.5 1.0 3.0 1.0 0.0 8.5 UL 
3 3.0 3.0 3.0 3.0 2.0 2.5 16.5 Uniform 
4 0.5 2.5 3.0 0.5 2.5 3.0 12.0 LL 
5 3.5 4.0 1.0 4.0 3.5 0.5 16.5 UL 
6 2,0 0.0 0.5 3,5 0,0 0.5 6.5 UL 
7 3.0 1.5 3.5 3.0 0.5 1.5 13.0 Asymmetric 
8 3.0 3.0 2.0 3.0 2.0 1.5 14.5 Asymmetric 
9 3.0~ 2.5 2.5~ 3.0:~ 2.5) 2.5§ 16.0 Uniform 
10 1.0 2.5 1.5 1.0 2.5 1.5 10.0 MUlingula 
11 3.5 1.5 2.0 3.5 1.0 2.0~: 13.5 UL 
12 2,5 2,0 1.5 2.5 1,5 2,5~ 12,5 Uniform 
13 0.5:~ 1.5 2.5~ 0.5~ 0.5 1.0~: 6.5 Asymmetric 
14 2.5 3.5 3.5 2.5 2.5 3.5 18.0 Uniform 
15 1,0 0,5 3.5 1,0 2,0 3,5 11.5 LL 
16 1,0 1,0 1,0 2,0 1,0 2,0§ 8,0 Uniform 
17 3.5 2.0 2.0 3.5§ 2.5 3.5 17.0 Asymmetric 
18 1,0 1,0 2,0 2,0 1,0 2.0 9.0 Uniform 
19 1,0 2,5 3,5 2,0 2,5 2,0§ 13,5 Asymmetric 
20 3.5 2.0 2.0 3.5 0.5 2.5 14.0 UL 
UL, Upper lobe; LL, lower lobe; ML, middle lobe. The extent of emphysematous changes ofeach individual lobe is scored for both panlobular nd 
centrilobular emphysema according tothe following scheme: 0,no emphysematous changes; 1,emphysematous changes involving <31)% of lobar parenchyma; 
2, involving 30%-60% of lobar pareachyma; 3. involving 60%-90% of lobar parenehyma; 4: >90% of lobar parenehyraa. 
*Severity score for each individual lobe is calculated byadding 100% of the score for pardobtdar and 50% of the score for centrilobular emphysema, 
respectively. 
?The emphysema type is determined by the distribution f the severity scores in the individual lobe. Unifonn, Lobar scores evenly distributed, the difference 
being <-1; ULYLL/MLeLIngula, bilateral predominance of the emphysema in the lobe indicated; Asymmetr/c. the lobar scores are unevenly distribnted~ there 
being no clear symmetric lobar predominance. 
~Bulla <2cm. 
§BuUa 2-5 cm. 
Methods 
Patient selection. Patients were referred from the Ger- 
man and Italian speaking parts of Switzerland (population 
5.28 million) and gave informed consent o be included in 
this prospective study of VAT-VRS performed by the 
same surgeon (W.W.). They were selected according to 
the following criteria: 
Inclusion criteria 
Severe obstruction (forced expiratory volume in 1 sec- 
ond [FEV~] < 1.2 Usec) without significant improve- 
ment by the usual antiobstructive pharmacotherapy, 
including a prolonged trial with systemic orticosteroids 
* Smoking cessation (carboxyhemoglobin < 2.0%) 
• High motivation and acceptance of an increased peri- 
operative mortality (estimated as being up to 10%) or 
morbidity, or both 
• Severe hyperinflation (total lung capacity [TLC] > 
130% of predicted) 
• Severe emphysema of the diffuse bilateral type with no 
isolated bullae occupying more than 20% of the volume 
of either hemithorax (according to Table I) 
• Dyspnea t rest or at minimal physical activity resulting 
in severe limitation of daily activity and an impaired 
quality of life 
Exclusion criteria: 
, Significant coronary artery heart disease (->50% diam- 
eter reduction of ->one coronary artery) 
• Mean pulmonary arterial pressure greater than 35 ram 
Ug 
• Carbon monoxide diffusing capacity (DLCO) less than 
20% of predicted or hypercapnia with an arterial carbon 
dioxide tension (Pat%) greater than 55 mm Hg 
• Active bronchopulmonary infection 
• Neoplastic disease with a life expectancy of less than 2 
years 
• Addiction to alcohol or drugs; psychiatric disturbance 
(e.g., panic disorder) 
• Serum creatinine level of 150/xg/ml or more; history of 
gastrointestinal bleeding in the previous year; abnormal 
results of liver function tests; active inflammatory bowel 
disease 
• Oral corticosteroids at a dose of more than 15 nag of 
prednisone quivalent 
Patient population, Within 1 year (from August 1994 
to August 1995) 60 patients were referred for evaluation. 
Twenty-nine patients were excluded from this study for 
the following reasons: unwilling to accept an increased 
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risk, 12; obvious gross bullous lung disease, 2; no hyper- 
inflation, 2; DLCO less than 20% of predicted, 1; severe 
coronary artery disease, 9; bronchial carcinoma, 2; drug 
addiction, 1. 
Twenty-five patients were accepted and six are being 
evaluated. Twenty were operated on and had 3 months' 
follow-up at the end of September 1995. The mean age of 
the 15 men and six women was 64 years (range 42 to 78 
years). Their mean body mass index was 21.5 kg/m 2 (range 
15.5 to 31.5 kg/m2). Twenty were former smokers, and two 
had cq-antitrypsin deficiency (ZZ, homozygosity for the 
allele Z). Seven patients were receiving long-term home 
oxygen therapy. 
Functional assessments. Measurements were per- 
formed within 2 weeks before the operation, before 
discharge, and 3 months after the intervention. 
Lung volumes were measured according to standard 
criteria11, 12 using the SensorMedics 66200 Autobox de- 
vice (SensorMedics Corp., Yorba Linda, Calif.). Results 
are expressed as the best values after inhalation of two 
puffs of salbutamol. 
DLCO was measured with the 66200/SensorMedics 
equipment. Reference values were according to the crite- 
ria of the European Community for Steel and Coal. 13 
Arterial blood gases were analyzed with an AVL 995-S 
device (AVL Medical Instruments, Schaffhausen, Switzer- 
land) and oxygen saturation and carboxyhemoglobin with 
a Co-Oximeter device (IL 482, Radiometer A/S, Copen- 
hagen, Denmark). 
Exercise was evaluated by the 12-minute walking dis- 
tance. The patients walked along the same hospital hall- 
way without oxygen supplementation, monitored by pulse 
oximetry, accompanied and encouraged by a techni- 
cian.14. 15 
Cardiopulmonary stress tests were performed by the 
SensorMedics 2900 metabolic measurement cart on an 
electronically braked cycle ergometer (Bosch; Medicare 
AG, Zurich, Switzerland). After 2 minutes of unloaded 
cycling at 50 rpm, the workload was increased by 5 W/min 
according to a ramp protocol until the patient was unable 
to continue. Maximal values for cardiorespiratory vari- 
ables were taken at the highest oxygen uptake. Predicted 
maximal heart rate was 215 beats/rain minus age (years). 
Right heart catheterization was performed in all patients. 
Coronary angiography was performed in 14 patients in 
whom coronary artery heart disease was suspected. 
Dyspnea was rated according to the American Thoracic 
Society's modified Medical Research Council score 16 and 
Mahler and associates' baseline and transition dyspnea 
index, t7 
High-resolution computed tomographic scanning was 
performed by a Somatom plus 4 device (Siemens AG- 
Bereich Medizinische Technik, Erlangen, Germany). 
Each patient's can was scored independently by two 
experienced readers blinded for clinical and functional 
data, according to an emphysema severity score that was 
defined beforehand (see legend to Table I). 
A lung perfusion scan was performed with a Siemens 
gamma camera (150 mBq technetium 99m-labeled mac- 
roalbumin particles). 
Anesthesia and postoperative management. A combi- 
nation of continuous thoracic epidural anesthesia nd 
total intravenous anesthesia was used. A left-sided dou- 
ble-lumen endotracheal tube was placed for one-lung 
ventilation. Controlled ventilation was performed with a 
Servo 900C ventilator (Siemens, Life Support Systems, 
Solna, Sweden). Extubation was performed in the operat- 
ing theater. Local anesthetics (Bupivacaine 0.25%) were 
given continuously through the epidural catheter. Periop- 
erative antibiotics were administered for 3 to 5 days. 
Surgical technique. Patients with emphysema localized 
predominantly to the upper or middle lobe, or both, were 
placed supine and the less-affected side was operated on 
first. If the resection was planned in the lower lobes or 
posteriorly, the patient was placed laterally and the posi- 
tion changed after completion of the first side. Three 11.5 
mm trocars (Thoracoport trocar, Auto Suture Company 
Division, United States Surgical Corporation, Norwalk, 
Conn.) were placed in the seventh or eighth intercostal 
space and a 5.5 mm trocar in the fourth intercostal space. 
A 10 mm rigid, 25-degree angled thoracoscope (OTV-SX, 
digital 3 CCD, Olympus America, Inc., Mellville, N.Y.) 
was used. The resection was planned by using computed 
tomographic scans and perfusion scintigraphy to identify 
the most severely destroyed tissues. The lack of resorption 
atelectasis was also helpful in identifying target areas for 
resection. In addition, "palpation" with an endoscopic 
lung forceps (Ethicon Endo-Surgery, Inc., Cincinnati, 
Ohio) was useful. Successive applications of endoscopic 
staplers (3.5 ram; Endo-GIA 30/60 mm staplers; Auto 
Suture) and more recently a 45 mm thoracoscopic endo- 
scopic linear cutter (Ethicon Endo-Surgery) were used to 
resect approximately 20% to 30% of lung volume. At 
intervals, the lung was reinflated to assess whether further 
resections were tolerable. The staplers were not but- 
tressed with xenopericardium. Pleural abrasion, pleural 
tent, and talc poudrage were not performed. Adhesions 
were dissected with endoscopic shears. Two drainage 
tubes were placed on each side and inserted through the 
trocars, applying suction of 10 to 20 cm H20. 
Statistical analysis. The data were checked for the type 
of distribution and the parameters were compared for 
paired samples by means of Student's t test or the 
Wilcoxon paired-sample test, accordingly. Correlation 
and standard linear regression were calculated between 
different parameters. Significance levels were p < 0.05. 
Results 
Perioperative and postoperative course and com- 
plications. Ten patients were operated on in the 
supine position and 10 in the lateral position with an 
intraoperative position change. Two patients had 
severe and six had minor adhesions. One patient 
had a tension pneumothorax during the operation, 
and this side was operated on subsequently. Cardio- 
pulmonary instability developed in two patients. 
Because the risk of operating on the other side was 
considered to be too high, only one side was re- 
sected. The mean duration of the operations was 
154 minutes (_+61) with a minimum of 65 minutes 
and a maximum of 290 minutes. All patients were 
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Table lI. Spirometry and lung volumes 
Before the operation: Before discharge: After 3 months: 
mean ± SD mean ± SD mean ± SD 
(range) (range) (range) 
FEV~ (L) 0.82 + 0.25 1.09 + 0.34? 1.09 ± 0.317 
(0.46-1.34) (0.53-2.08) (0.53-1.76) 
% Predicted 29 ±_ 7.4 39 ± 10.5 39 ± 9.7 
(18-49) (23-64) (24-60) 
FVC (L) 2.54 ± 0.80 2.95 ± 0.81" 3.27 ± 0.62? 
(1.47-4.33) (1.76-5.24) (2.11-4.51) 
% Predicted 70 +-_ 16 84 ± 16 94 +_ 13 
(47-99) (58-116) (67-116) 
TLC (L) 8.78 ± 1.43 6.8 -+ 1.40:~ 7.34 ± 1.23" 
(6.3-12.0) (5.0-9.9) (5.9-9.9) 
% Predicted 145 ± 21 123 ± 21 129 + 20 
(98-185) (87-160) (87-169) 
IVC (L) 3,03 ± 1.02 2.84 ± 0.95 3.51 ± 0.86* 
(1.04-4.77) (1.19-4.36) (1.13-4.82) 
RV (L) 5.6 ± 1.3 4,15 ± 0.9:) 4.3 ± 0.9~ 
(4.0-10,4) (2.3-5.8) (2.5-6.0) 
% Predicted 256 -+ 71 195 +- 48 197 ± 51 
(154-432) (114-276) (120-300) 
RV/TLC (%) 0.64 ± 0,09 0.57 + 0,07t 0.55 ± 0.07:~ 
(0.48-0.87) (0.45-0.71) (0.42-0.68) 
SD, Standard eviation; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; WC, inspiratory vital capacity; 
TV, residual volume. 
*p < 0.05 compared with preoperative alue. 
tp < 0.01 compared with preoperative alue. 
:]:p < 0.001 compared with preoperative alue. 
TLC, total ung capacity; 
extubated immediately atthe end of the operation. 
In one patient endotracheal reintubation was neces- 
sary 30 minutes later because of severe alveolar 
hypoventilation with a Pacoa rising to 80 mm Hg. He 
was successfully extubated 20 hours later. 
Twelve of the 20 patients had an uneventful 
perioperative and postoperative course. The re- 
maining eight had one or two of the following 
complications. Six had bacterial pneumonia, which 
was successfully treated by antibiotics. Despite a 
lack of previous air leaks, a pneumothorax occurred 
during chest physiotherapy in two patients after the 
chest ubes had been removed. One patient required 
rethoracoscopy on the sixteenth postoperative day, 
although no air leak could be identified. A pleural 
abrasion was performed. The median chest tube 
drainage time was 6.5 days (range 3 to 19 days). In 
seven patients drainage time was prolonged (i.e., 
more than 7 days). The median stay in the hospital 
was 15 days, ranging from 7 to 26 days. 
No early or late deaths occurred. Two patients 
had prolonged chest pain at the operation port. 
They had clinical signs of rib fractures caused by 
severe osteoporosis after long-term corticosteroid 
therapy. Three patients had an incomplete unilat- 
eral pneumothorax between 6 and 8 weeks after 
discharge from the hospital. In two patients the 
pneumothorax occurred spontaneously and in one 
as a complication of an intercostal nerve blockade. 
All were treated by simple thoracic tube drainage 
and no further events occurred. 
Funct ional  results. The preoperative and postop- 
erative functional data are summarized in Tables II to 
IV. The mean increase in FEV1 was 42%. The full gain 
in FEV1 was reached before discharge (Table II). In 
four patients the changes in FEV1 were less than 150 
ml, but none showed worsening of FEV 1 or vital 
capacity compared with preoperative alues. In eight 
patients the increase in FEV~ was more than 300 ml, in 
one patient FEV1 improved by 740 ml, and in another 
by 830 ml. Residual volume (RV) decreased by a mean 
of 1.45 L. In three patients the reduction of RV was 
less than 0.5 L, but in 11 patients RV declined by more 
than 1 L from the preoperative measurement. The 
mean difference in TLC was 1.0 L. In four patients the 
difference in TLC from baseline was 0.5 L or less. 
Accordingly, the mean RV/TLC ratio had decreased 3 
months after the operation (see Table II). 
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Table III. Gas exchange and pulmonary hemodynamics 
Before the operation: After 3 months: 
mean +_ SD mean +_ SD 
(range) (range) p Value 
Pao 2 (ram Hg) 67 - 8.7 71 _+ 9.6 p < 0.05 
(54-90) (54-98) 
Paco: (mm Hg) 37 + 4.2 35 + 3.9 p < 0.05 
(28-46) (27-42) 
D(A-a)Po z (mm Hg) 28 _+ 10.7 29 _+ 8.9 NS 
(7-44) (11-42) 
DLCOsB (% pred) 41 _+ 10.0 44 _+ 9.1 NS 
(2448) (28-61) 
PAPs (mm Hg) 30 _+ 4.6 - -  - -  
PAPd (mm Hg) 12 _+ 2.9 - -  - -  
PAPm (mm Hg) 19 _+ 3.1 - -  - -  
PCPm (mm Hg) 8 _+ 3.3 - -  - -  
CO (L/min) 4.6 _+ 0.75 - -  - -  
PVR (dyn. sec- cm 5) 210 _+ 89 - -  - -  
SD, Standard eviation; Pao2, arterial oxygen tension; Paco2, arterial carbon dioxide tension; D(A-a)Po2, alveolar-arterial oxygen pressure gradient; 
DLCOsB, single-breath carbon monoxide diffusing capacity; PAPs', systolic pulmonary artery pressure; PAPd, diastolic pulmonary artery pressure; PAPm, 
mean pulmonary artery pressure; PCPm, mean pulmonary capillary pressure; CO, cardiac output; PVR, pulmonary vascular resistance; NS, not significant. 
None of our patients had a DLCO above 60% of 
predicted before the operation. No significant 
changes were observed after VRS (see Table III). In 
three patients the arterial oxygen tension (Pao2) at 
rest was below 60 mm Hg and in two of them it was 
lower than 55 mm Hg. Three months after VRS we 
found a mild but significant increase in the mean 
Pao 2 of 4 _+ 0.71 mm Hg (p < 0.01). There was also 
a small but significant drop in the mean Paco 2. This 
explains why the alveolar-arterial oxygen pressure 
gradient remained unchanged (see Table III). In 
only one of the three patients who had a Pao2 below 
60 mm Hg before the operation, the Pao 2 increased 
relevantly from 54 to 69 mm Hg (at rest). The 
hemodynamic data of the right heart catheteriza- 
tions are presented in Table III. One patient had 
mild pulmonary hypertension with a mean pulmo- 
nary artery pressure of 25 mm Hg. 
Both exercise capacity and the 12-minutes walk- 
ing distance were significantly better after VRS. 
Three months after the operation, maximal minute 
ventilation was higher by a mean of 8 L/rain. 
Except in one patient, a clear relief of dyspnea 
occurred after VRS. Three of the patients in whom 
the FEV 1 did not improve significantly (i.e., an 
increase <0.15 L) reported a clear subjective im- 
provement. The Medical Research Council dyspnea 
score diminished from a mean of 3.9 (_+0.67) to 1.8 
(+0.90). Breathlessness, as assessed by Mahler's 
dyspnea transition index, ~7 decreased in 15 of the 20 
patients at least moderately (->+2). In the one 
patient who reported no subjective amelioration, the 
change in FEV 1 was only 0.13 L. In contrast, hree 
patients in whom neither a significant improvement 
of FEV1 nor a reduction of hyperinflation could be 
documented reported a mild subjective benefit (+ 1 
Mahler's dyspnea transition index). 
Taking the changes in Medical Research Council 
dyspnea scores as dependent and changes in FEV1 and 
RV as independent variables, we found moderate 
correlations between the improvement i  dyspnea nd 
the reduction in air flow obstruction (r = 0.44; p < 
0.01), as well as in the decrease of hyperinflation (r = 
0.42; p < 0.001). Furthermore, we found a good 
correlation between the reduction in dyspnea score 
(Medical Research Council) and the improvement in 
exercise capacity (r = 0.73; p < 0.01). The improve- 
ment in dyspnea chieved by VRS correlated only with 
the preoperative d gree of airflow obstruction (FEV1; 
r = -0.41; p < 0.01) but not with the degree of 
hyperinflation before the operation. 
Discussion 
Severe forms of chronic obstructive pulmonary 
disease are characterized by a considerable degree 
of pulmonary emphysema, which is defined as per- 
manent enlargements of air spaces distal to the 
terminal bronchioles accompanied by destructions 
of their wallsJ s In patients with this variety of 
disease, little or no change in lung function is 
produced by extensive antiobstructive pharmaco- 
therapy or after pulmonary rehabilitation. 19 For 
patients with severe impairment who are younger 
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Table IV. Cardiopulrnonary exercise tests 
Before the operation: After 3 months: 
mean ~ SD mean ± SD 
(range) (range) p Value 
Twelve-minute walking distance (*) (m) 
Maximal workload (W) 
VO2max (ml/kg/min) 
D(A-a)Po 2 (mm Hg) 
Vzmax (L/min) 
Breathing reserve (L/min) 
Heart rate max (beats/min) 
495 688 0.0001 
(35-790) (175-1035) 
31 +- 12 47 --+ 14 0.0001 
(10-55) (20-70) 
10 + 2.5 13 ___ 2.3 0.0005 
(5-16) (9-18) 
36.2 + 9.8 43.0 +_ 9.9 0.01 
(19.2-56.6) (14.9 -+ 58.3) 
29 + 9 38 - 8 0.0006 
(18-48) (22-54) 
0.1 ± 5.6 1.5 -+ 6.7 0.44 
(-12-10) (-9-16) 
123 ± 18 132 ± 15 0.04 
(98-167) (101-158) 
VO2rnax, Maximal oxygen uptake; D(,4-a)Po2, alveolar-arterial oxygen pressure gradient at maximal exercise; VEmax, maximal minute ventilation. (FEV1 × 
37)-VE max. 
*Median. 
than 60 years, single or double lung transplantation 
remained until recently the only promising thera- 
peutic option. 2°' 21 
Cooper and associates m published impressive im- 
provements in dyspnea nd pulmonary function by 
bilateral surgical ung volume reduction in 20 pa- 
tients with severe diffuse pulmonary emphysema. 
Since then this group has accumulated extensive 
experience with more than 100 patients. Many other 
groups in the United States and Europe are now 
performing VRS and have presented their prelimi- 
nary results at international meetings. 
The degree of functional impairment of our study 
population (see Tables II to IV) is comparable with 
that of Cooper's patients, mThe mean FEV1 of 0.77 L, 
mean RV of 5.9 L, mean TLC of 8.5 L, and mean Pao2 
of 64 mm Hg of their patients are almost identical to 
our measurements. Their patients had a mean age of 
56 years, somewhat younger than the mean age of 64 
years of our patients. We are not able to compare the 
morphologic type and the distribution of pulmonary 
emphysema between Cooper's and our groups, be- 
cause there is no generally accepted radiologic lassi- 
fication and grading system for emphysema. Neverthe- 
less, as can be seen in Table I, all our patients had 
pulmonary emphysema of the diffuse type and none of 
the bullous type. 
In contrast to Cooper and coworkers, 1°who used 
median sternotomy, we performed VRS by VAT. In 
two patients we decided not to resect he other lung, 
because the condition of the patients became unsta- 
ble during the operation. However, the postopera- 
tive course in both patients was without complica- 
tion. Although we did not use pericardial strips to 
buttress the stapler lines, 22 our experience is com- 
parable with the results of Cooper's group, 1° who 
reported prolonged air leaks in 11 of their 20 
patients. This low complication rate is also reflected 
in a median hospital stay of 15 days, comparable 
with the hospitalization time reported by Cooper's 
group. In our study population, selected by previ- 
ously defined stringent criteria, we had no early or 
late mortality. 
The improvements of pulmonary mechanics 
achieved by VAT-VRS were highly significant and 
of clinical relevance. However, in contrast to 
Cooper's group, 1° which obtained a mean increase 
in FEV1 of 82% from 0.77 to 1.4 L by performing 
VRS by sternotomy, we obtained a mean increase of 
42% (from 0.8 to 1.1 L). The reduction in hyperin- 
flation in our study group was also somewhat less 
than after VRS by sternotomy. 1° Our smaller gains 
in FEV1 may be due to several factors. We had a 
smaller number of patients with predominant upper 
lobe emphysema, those believed to profit most from 
VRS. However, our small series does not allow us to 
draw any reliable conclusions about a correlation 
between the type of emphysema and the degree of 
postoperative functional benefit. In addition, two 
patients did not undergo resection on both lungs as 
planned because of cardiopulmonary instability. 
However, it is obvious that functional improvements 
after bilateral resection are better than after unilat- 
eral VRS. Furthermore, it is possible that more 
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emphysematous l ng tissue was removed by sternot- 
omy than by VAT. The results of pulmonary func- 
tion tests immediately before discharge were similar 
to functional data at 3 months. This has not been 
observed after VRS by sternotomy, in which maxi- 
mal improvements in pulmonary function are 
reached between 3 and 6 months after the opera- 
tionJ ° Whether this early functional recovery is due 
to the thoracoscopic approach remains peculative, 
because no data are available regarding pulmonary 
function measurements early in the postoperative 
course after sternotomy. We decided to perform 
VRS by VAT for the following reasons. VAT pro- 
vides agood view and access to all parts of the lungs, 
including the posterior and inferior aspects. It allows 
precise dissection of adhesions even in those areas 
that are difficult to reach through a sternotomy. 
Adhesions were observed in almost half of our 
patients. Their dissection can lead to air leaks. 
Wedge resection by VAT can be performed in any 
region without overly manipulating the lungs by 
mobilizing them into the operative field. Further- 
more, we consider the inability of manual palpation 
to select areas of resection unimportant, because we 
primarily use imaging modalities uch as computed 
tomographic and perfusion scans to identify target 
areas for resection. However, we encountered some 
difficulties in recognizing and localizing air leaks, if 
present, at the end of the procedure. 
We found no changes in DLCO (see Table III), a 
parameter believed to reflect he amount of pulmo- 
nary gas exchange surface. 23 These findings are a 
strong argument that we did not remove relevant 
quantities of tissue, which contributed to gas ex- 
change. Ventilation-perfusion mismatch is another 
cause of hypoxemia npatients with chronic obstruc- 
tive pulmonary disease and emphysema. It is there- 
fore conceivable that the improvements in pulmo- 
nary mechanics are accompanied by a rise in Pao2. 
Cooper and associates w observed a slight increase 
in the mean Pao2 of their patients, the Paco2 
remaining unchanged. We too found a small but 
significant rise in the mean Pao2 in our study 
population. In contrast, the mean Paco z in our 
patients decreased significantly (see Table III). 
Hence the alveolar-arterial oxygen gradient re- 
mained unchanged and the increase in Pa02 might 
be attributed to a slightly augmented alveolar ven- 
tilation. 
Pulmonary function does not improve after pul- 
monary rehabilitation. In contrast, rehabilitation 
may increase walking distance, maximal workload, 
and endurance time in severely impaired but highly 
motivated patients) 9 This was the case in Cooper's 
patients, who underwent a structured rehabilitation 
program before VRS or lung transplantationJ ° The 
improvement in 12-minute walking distance of our 
patients was moderate. Our findings are difficult to 
compare with those of Cooper's group, 1° who as- 
sessed physical performance by measuring the 
6-minute walking distance. We are not able to 
compare our improvements, documented by stan- 
dardized cardiopulmonary exercise tests, with the 
findings of others, because results of exercise tests 
after VRS have not yet been published. Since only 
two of our patients underwent a rehabilitation pro- 
gram after the operation, we believe that the mean 
improvement in exercise performance of our study 
population ismainly due to changes in lung mechan- 
ics. 
The relation between breathlessness and param- 
eters such as dynamic expiratory flow rates, static 
lung volumes, and arterial blood gases overlap wide- 
ly. z4 We found moderate correlations between the 
improvements in shortness of breath and alterations 
in lung mechanics achieved by VRS. Even patients 
who showed no objective changes, as assessed by 
conventional pulmonary function tests, reported a
marked subjective benefit. A somewhat better cor- 
relation was detected between the reduction in the 
Medical Research Council dyspnea score and an 
amelioration i exercise performance. The contribu- 
tion of a placebo effect in these highly motivated 
patients cannot be excludedY Furthermore, 
changes in pulmonary mechanics, which are not 
detected by conventional measurements (e.g, dia- 
phragmatic function and breathing pattern), might 
play a significant role. 
We are grateful to Mrs. H. Shang for her help in the 
preparation of the manuscript. 
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